Radiofrequency induction on sodium/iodide symporter expression of thyroid cancer

By Tian Youxin   Liu Qinjiang   Ni Yaqiong  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 516-520

Springer Publishing Company

Access to resources Recommend Favorite

Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer Tissue

By Upadhyay G.  

Breast Cancer Research and Treatment, Vol. 77, Iss. 2, 2003-01 ,pp. : 157-165

Springer Publishing Company

Access to resources Recommend Favorite

Determination of the optimal time for radioiodine therapy in anaplastic thyroid carcinoma using the adenovirus-mediated transfer of sodium iodide symporter gene

By        

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1666-1670

Spandidos Publications

Access to resources Recommend Favorite

Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer

By              

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 59-66

Spandidos Publications

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N.   Catalano M.   Marano F.   Mugoni V.   Pugliese M.   Bosco O.   Mainini F.   Boccuzzi G.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite